Unique ID issued by UMIN | UMIN000033789 |
---|---|
Receipt number | R000038535 |
Scientific Title | The effects of dietary novel chocolate on postprandial blood glucose level in healthy adult men |
Date of disclosure of the study information | 2019/03/01 |
Last modified on | 2019/08/14 13:36:51 |
The effects of dietary novel chocolate on postprandial blood glucose level in healthy adult men
The effects of dietary novel chocolate on postprandial blood glucose
The effects of dietary novel chocolate on postprandial blood glucose level in healthy adult men
The effects of dietary novel chocolate on postprandial blood glucose
Japan |
Healthy adult males
Adult |
Others
NO
We randomly allocated twelve subjects to administer either the novel chocolate or the control chocolate to investigate the postprandial blood glucose level, followed by a washout period. These subjects were then crossed over and received the alternative chocolate.
Safety,Efficacy
Blood glucose level, the blood glucose areas under the curve (AUC), the maximum (Cmax) blood glucose level
Blood insulin level, the blood insulin areas under the curve (AUC), the maximum (Cmax) blood insulin level
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Placebo
2
Treatment
Food |
Single dose administration of 65 g of the novel chocolate in intervention period
Single dose administration of 65 g of the control chocolate in control period
40 | years-old | <= |
Not applicable |
Male
1) All subjects voluntarily signed the informed consent after detailed description and understanding of this study
2) Those who belong to a particular company.
3) Subjects with fasting blood glucose level within normal range between 70 mg/dL and 110 mg/dL using the first blood test.
1) Those who administer 'Food for Specified Health Use','Foods with Function Clai s' or medicine to have effects on blood glucose metabolism.
2) Patients with diseases undergoing treatments or with medical history of severe diseases that required medication therapy.
3) Those who may suffer from allergy by administering cacao, milk or soybean.
4) Those who were included other clinical trials within one month before giving written informed consent, or during this study.
5) Any other medical and/or health reasons unfavorable to participation in this study, as judged by the principal investigator.
12
1st name | |
Middle name | |
Last name | Takeshi Kurihara |
Kurihara Clinic, Nihonbashi, Tokyo
Kurihara Clinic, Nihonbashi, Tokyo
3-2-6 Nihonbashi, Chuoku, Tokyo 103-0027
03-3516-2200
kurihara@k-sarasara.com
1st name | |
Middle name | |
Last name | Takaya Kitamura |
Meiji Co., Ltd.
Clinical Study Group
1-29-1 Nanakuni, Hachiouji, Tokyo 192-0919
042-632-5807
takaya.kitamura@meiji.com
Meiji Co., Ltd.
Meiji Co., Ltd.
Profit organization
Japan
NO
栗原クリニック 東京・日本橋(東京都)
2019 | Year | 03 | Month | 01 | Day |
Published
10
1) Blood glucose at 30 minutes after ingestion of the test diet was significantly lower than after ingestion of the control diet.
2) Plasma insulin levels at 30 and 60 minutes after ingestion of the test diet were also significantly lower than after ingestion of the control diet.
3) The change in area under the curve(delta AUC)of plasma insulin levels following ingestion of the test diet was significantly lower than that following ingestion of the control diet.
2019 | Year | 08 | Month | 14 | Day |
2019 | Year | 07 | Month | 30 | Day |
None
Completed
2018 | Year | 08 | Month | 06 | Day |
2018 | Year | 08 | Month | 07 | Day |
2018 | Year | 08 | Month | 18 | Day |
2018 | Year | 08 | Month | 27 | Day |
2018 | Year | 08 | Month | 17 | Day |
2019 | Year | 08 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038535